Home › NDC Lookup › RxCUI directory › RxCUI 858342

Diclofenac 25 MG Oral Capsule — RxCUI 858342

RxNorm drug concept · Semantic clinical drug
RxCUI 858342 Semantic clinical drug · SCD ● Current RxNorm concept 11 FDA products 13 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI858342
Official nameDiclofenac 25 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdiclofenac 25 MG (equivalent to diclofenac potassium 28.3 MG) Oral Capsule; diclofenac potassium 25 MG Oral Capsule
FDA products mapped11
Package NDCs mapped13
Reported Medicaid activity (SDUD)1,081 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Diclofenac Ophthalmic: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Diclofenac sodium eye drops are an anti-inflammatory medication used after eye surgery. If you had cataract surgery, they help control swelling and inflammation in your eye during...
  • Yes, that's very common. About 15% of patients notice temporary burning or stinging right after applying the drop. It usually settles within a minute or so. If the burning is sever...
  • My eye burns a little when I put the drop in — is that normal?
  • While most side effects are mild, there have been rare but serious reports of corneal problems — including thinning or ulceration of the clear surface of the eye. If you notice sud...
📖 Read our full Diclofenac Ophthalmic guide →

🕸️ Concept Web — How Diclofenac 25 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Diclofenac 25 MG Oral Capsule RxCUI 858342

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Diclofenac 3355
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Zipsor 858343
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Diclofenac Oral Capsule 376352
    • Diclofenac Oral Product 1151152
    • Diclofenac Pill 1151153
    • Diclofenac Oral Capsule [Zipsor] 858345
    • Zipsor Oral Product 1187666
    • Zipsor Pill 1187667
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Diclofenac 25 MG SCDC · 2670401
  • Diclofenac Oral Capsule SCDF · 376352
  • Diclofenac Oral Product SCDG · 1151152
  • Diclofenac Pill SCDG · 1151153

Brand-Name Concepts

  • Diclofenac 25 MG Oral Capsule [Zipsor] SBD · 858346
  • Diclofenac 25 MG [Zipsor] SBDC · 2670403
  • Diclofenac Oral Capsule [Zipsor] SBDF · 858345
  • Zipsor Oral Product SBDG · 1187666
  • Zipsor Pill SBDG · 1187667
  • Zipsor BN · 858343

📦 FDA Products & Package NDCs

11 products · 13 package NDCs
13 package NDCs map to RxCUI 858342 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00480-9435-89 120 CAPSULE, LIQUID FILLED in 1 BOTTLE (0480-9435-89) Diclofenac potassium TEVA PHARMACEUTICALS, INC. 2022-03-24
13913-0008-12 120 CAPSULE, LIQUID FILLED in 1 BOTTLE (13913-008-12) ZIPSOR Assertio Therapeutics, Inc. 2015-12-01
23155-0840-12 120 CAPSULE, LIQUID FILLED in 1 BOTTLE (23155-840-12) diclofenac potassium Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 2022-11-21
59088-0131-73 120 CAPSULE, LIQUID FILLED in 1 BOTTLE (59088-131-73) Diclofenac Potassium PureTek Corporation 2026-04-10
59651-0353-01 100 CAPSULE, LIQUID FILLED in 1 BOTTLE (59651-353-01) Diclofenac Potassium Aurobindo Pharma Limited 2022-03-14
59651-0353-08 120 CAPSULE, LIQUID FILLED in 1 BOTTLE (59651-353-08) Diclofenac Potassium Aurobindo Pharma Limited 2022-03-14
62135-0469-12 120 CAPSULE, LIQUID FILLED in 1 BOTTLE (62135-469-12) Diclofenac Potassium Chartwell RX, LLC 2023-02-12
63629-4871-01 30 CAPSULE, LIQUID FILLED in 1 BOTTLE (63629-4871-1) Diclofenac potassium Bryant Ranch Prepack 2025-01-17
64380-0841-06 100 CAPSULE, LIQUID FILLED in 1 BOTTLE (64380-841-06) diclofenac potassium Strides Pharma Science Limited 2022-09-20
64380-0841-11 120 CAPSULE, LIQUID FILLED in 1 BOTTLE (64380-841-11) diclofenac potassium Strides Pharma Science Limited 2024-12-28
69315-0275-20 120 CAPSULE, LIQUID FILLED in 1 BOTTLE (69315-275-20) Diclofenac Potassium Leading Pharma, LLC 2022-03-24
71335-2550-01 30 CAPSULE, LIQUID FILLED in 1 BOTTLE (71335-2550-1) Diclofenac Potassium Bryant Ranch Prepack 2025-01-21
72336-0432-12 120 CAPSULE, LIQUID FILLED in 1 BOTTLE (72336-432-12) Diclofenac Potassium Lifsa Drugs LLC 2025-05-01
Observed labelers: Aurobindo Pharma Limited (2) · Bryant Ranch Prepack (2) · Strides Pharma Science Limited (2) · Assertio Therapeutics, Inc. (1) · Chartwell RX, LLC (1) · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. (1) · +4 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$3.0882
Range $3.0882–$3.0882 · middle 50% $3.0882–$3.0882 · 6 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.